Dow Down0.62% Nasdaq Down1.14%

Galectin Therapeutics, Inc. (GALT)

-NCM
5.24 Down 0.04(0.76%) 4:00PM EDT
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Net Income (12,088) (9,675) (10,915)
Operating Activities, Cash Flows Provided By or Used In
Depreciation12  9  9  
Adjustments To Net Income3,789  2,792  3,769  
Changes In Accounts Receivables -   -  234  
Changes In Liabilities842  (571)1,261  
Changes In Inventories -   -   -  
Changes In Other Operating Activities(39)(55)(34)
Total Cash Flow From Operating Activities (7,484) (7,500) (5,676)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures -  (5)(5)
Investments -   -   -  
Other Cash flows from Investing Activities -  69  (10)
Total Cash Flows From Investing Activities -   64   (15)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock8,609  10,403  6,197  
Net Borrowings -   -   -  
Other Cash Flows from Financing Activities -   -   -  
Total Cash Flows From Financing Activities 8,609   10,403   6,197  
Effect Of Exchange Rate Changes -   -   -  
Change In Cash and Cash Equivalents 1,125   2,967   506  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.